FDA clears SCENERGY system from Clear Guide Medical

Clear Guide Medical, a healthcare technology company based in Baltimore, announced today that it has received 510(k) clearance from the FDA for its CT-Ultrasound fusion and image guidance system known as SCENERGY.

Sold as an accessory to ultrasound machines, the device uses an integrated display of fused ultrasound and CT images to assist interventional radiologists and surgeons with minimally-invasive biopsies as well as other diagnostic and therapeutic procedures.

"SCENERGY is a real advance for image-guided interventions," said company CTO Philipp Stolka, PhD, in a press release. "Because SCENERGY is installed onto existing equipment, it can quickly be adopted in many different locations, benefitting patients sooner. We believe that its unique dynamic registration approach solves many problems that hindered the adoption of other guidance technologies."

Read the full press release here.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.